BOLD
Boundless Bio, Inc.
2.50$
-2.0%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 94.6% | 95.6% | 95.8% | 97.3% | 97.3% | 74.8% | 73.4% | 72.3% | 71.2% | 69.8% | 67.1% | 99.9% | |
| 14.6% | 18.3% | 21.5% | 16.7% | 23.0% | 12.9% | 7.9% | 8.2% | 8.9% | 11.4% | 12.4% | 27.4% | |
| 92.3% | 93.0% | 89.6% | 95.3% | 95.5% | 73.7% | 72.3% | 70.9% | 69.7% | 68.5% | 65.9% | 98.5% | |
| 180.7% | 197.8% | 220.6% | 4.8% | 5.7% | 27.0% | 28.6% | 31.6% | 34.7% | 37.2% | 38.7% | 10.5% | |
| 7.2% | 7.2% | 9.1% | 4.8% | 5.7% | 3.9% | 3.3% | 5.1% | 7.0% | 8.0% | 6.8% | 10.5% | |
| 1.8% | 1.7% | 1.3% | 0.4% | 0.1% | – | 0.1% | 1.1% | 1.8% | 2.0% | 2.3% | – | |
| 0.6% | 1.7% | 2.5% | 0.9% | 1.5% | 0.6% | 0.7% | 1.3% | 0.7% | 0.9% | 1.4% | 6.8% | |
| -80.7% | -97.8% | -120.6% | 95.2% | 94.3% | 73.0% | 71.4% | 68.4% | 65.3% | 62.8% | 61.3% | 89.5% | |
| -86.2% | -104.8% | -129.4% | -89.5% | -105.7% | -97.6% | -113.6% | -129.8% | -146.3% | -165.3% | -193.8% | -402.6% | |
| 15.5% | 17.1% | 19.0% | 11.7% | 12.7% | 8.2% | 11.7% | 12.5% | 13.3% | 14.2% | 15.9% | 30.4% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.